Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Less vigorous surgery for second primary lung cancer.

A Iwasaki1, T Shirakusa, T Hamada

  • 1Second Department of Surgery, School of Medicine, Fukuoka University, 45-1, 7-chome Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan. akinori@fukuoka-u.ac.jp

The Thoracic and Cardiovascular Surgeon
|August 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pericytes Are Odontoblast Progenitor Cells Depending on ER Stress.

Journal of dental research·2025
Same author

Publisher Correction: A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Isotropy of Cosmic Rays beyond 10^{20}  eV Favors Their Heavy Mass Composition.

Physical review letters·2024
Same author

An extremely energetic cosmic ray observed by a surface detector array.

Science (New York, N.Y.)·2023
Same author

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Hydrocephalus due to marked enlargement of spinal roots in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.

European journal of neurology·2020

Less invasive surgeries like segmentectomy or video-assisted thoracic surgery (VATS) show promise for treating second primary lung cancer (SPLC), with comparable survival rates and reduced blood loss compared to conventional thoracotomy.

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Pulmonology

Background:

  • Second primary lung cancer (SPLC) presents a heterogeneous patient population.
  • Optimal treatment strategies for SPLC remain undetermined.
  • Investigating less invasive surgical options is crucial for SPLC management.

Purpose of the Study:

  • To evaluate the efficacy of less vigorous surgical therapies for SPLC.
  • To compare segmentectomy or VATS lobectomy with conventional thoracotomy lobectomy.
  • To determine the feasibility of minimally invasive approaches in SPLC treatment.

Main Methods:

  • Retrospective review of 46 SPLC patients undergoing resection.
  • Group classification: Less Vigorous Therapy (LVT) including segmentectomy/VATS lobectomy vs. Less Conventional Thoracotomy (LCT).

Related Experiment Videos

  • Analysis of patient characteristics and 5-year survival rates post-surgery.

    • Main Results:

    • LVT group exhibited significantly less blood loss (59.44 ml) compared to LCT (254.48 ml).
    • No postoperative complications were observed in the LVT group.
    • 5-year survival rates were comparable: 62.7% for LVT and 57.7% for LCT.

    Conclusions:

    • Less invasive surgeries, including VATS and segmentectomy, are feasible treatments for SPLC.
    • Minimally invasive approaches offer potential benefits in blood loss and complication rates.
    • Surgical modality choice should consider patient heterogeneity in SPLC.